CTU: An Open-Label, Multi-Center Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of SHR-A1921 for Injection in Subjects with Advanced Solid Tumors

  • Park, John (Primary Chief Investigator)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Keshiya, Shikara (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleSHR-A1921-I-102
StatusFinished
Effective start/end date29/03/2313/11/23